ArticleEuropean heart journal. Cardiovascular Imaging2018

Validation of 2-year 123I-meta-iodobenzylguanidine-based cardiac mortality risk model in chronic heart failure.

Kenichi Nakajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.